Status:
COMPLETED
Comparison of the Effects of Cervical Vasopressin Versus no Premedication on Blood Loss During Vaginal Hysterectomy: A Randomized, Placebo Controlled Trial
Lead Sponsor:
Ascher-Walsh, Charles, M.D.
Conditions:
Blood Loss During Vaginal Hysterectomy
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
Vasoconstrictive agents are increasingly being used in order to decrease blood loss during vaginal hysterectomy. The first reported study of the use of a vasoconstrictive agent for this purpose was on...
Eligibility Criteria
Inclusion
- women greater that 18 undergoing vaginal hysterectomy for any indication, with or without concomitant procedures
Exclusion
- women with a significant medical condition, including severe liver disease, congestive heart failure, documented coronary artery disease, impaired renal function determined by an elevated serum creatinine, asthma with steroid use in the past year, and migraines
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2005
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT00799292
Start Date
January 1 2004
End Date
January 1 2005
Last Update
July 24 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032